DCM
AMPH icon

Driehaus Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Driehaus Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-57,300
Closed -$1.14M – 398
2018
Q4 		$1.14M Buy
+57,300
New +$1.13M 0.05% 269
2018
Q1 		– Sell
-11,902
Closed -$229K – 487
2017
Q4 		$229K Buy
+11,902
New +$222K 0.01% 499

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Driehaus Capital Management's AMPH Position: Q1 2019 in Review

Driehaus Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2019, closing a stake of 57,300 shares — an estimated $1.14M sold.

Driehaus Capital Management first reported a position in AMPH in Q4 2017 and held it in 2 quarters. The position peaked at $1.14M in Q4 2018. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2019.

  • Driehaus Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Driehaus Capital Management sold 57,300 Amphastar Pharmaceuticals shares in Q1 2019, an estimated $1.14M.
  • Driehaus Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Driehaus Capital Management's Amphastar Pharmaceuticals position peaked at $1.14M in Q4 2018.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2019.

Based on Driehaus Capital Management's 13F filing for Q1 2019, filed 15 May 2019.